In addition to that, HER-2/neu-mediated Akt activation phosphorylates MDM2 to enhance p300 interaction and inhibits p19ARF interaction, resulting in increased degradation of p53 and blocked cytotoxic effect of DNA damage agents in cancer cells (Zhou et al., 2001). This evidence concerns the gene ERBB2 and cancer.